BioSpace News Archive

Aidoc, the leading provider of AI solutions for radiologists, announced that the US Food and Drug Administration has cleared its AI solution for flagging Large-Vessel Occlusion in head CTA scans, marking Aidoc’s fourth FDA-cleared AI package.

The Muscular Dystrophy Association and AavantiBio, a biotechnology company developing a gene-targeting therapy for Friedreich’s ataxia, announced the award of MDA Venture Philanthropy funding totaling $1,076,232 to advance AavantiBio’s phase 2 clinical trial of a gene-replacement therapy for the disease.

VALTOCO (diazepam nasal spray) is approved by the U.S. Food and Drug Administration (FDA) for use by a care partner outside of the medical setting for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patient’s usual seizure pattern

Stephen Dilly Appointed as Chairman of Board of Directors

New partnerships further Cigna’s strategy to connect customers to care everywhere and meet them where they are - at home, at work, on the go

Kap-Seok Yang, CEO of Macrogen, announced on January 13 that the company has signed a strategic License and Supply Agreement with Thermo Fisher Scientific.

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on multimodal, disease-modifying therapies for neurodegenerative diseases, announced that it will present at Biotech Showcase 2020, to be held January 13-15, 2020 at the Hilton San Francisco Union Square.

Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, announced that 11 new partner programs entered clinical development in 2019.

Top academic medical center to leverage leading breast health data tool to improve breast screening protocols for groundbreaking study

LineaRx will incorporate LifeSensors’ SUMO-fusion technologies to maximize protein expression of PCR-produced Linear DNA